Sacubitril And Valsartan Tablet, Film Coated
Product Images NDC 70069-855

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Sacubitril And Valsartan (NDC 70069-855). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 01)

FDA Label Image

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 02)

FDA Label Image

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 03)

FDA Label Image

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 04)

FDA Label Image

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 05)

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 05)
This is a detailed breakdown of the population under study, divided into various subgroups based on factors such as age, gender, weight, race, region, NYHA class, diabetes, blood pressure, ejection fraction, atrial fibrillation, NT-proBNP levels, hypertension, prior use of ACE inhibitors, ARBs, aldosterone antagonist, hospitalization for heart failure, time since heart failure diagnosis, and cause of heart failure. The hazard ratios for the different subgroups are provided, comparing Enalapril with Sacubitril and Valsartan. This information can be used to analyze the effectiveness of Enalapril compared to Sacubitril and Valsartan in different patient groups.*
FDA Label Image

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 06)

FDA Label Image

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 07)

FDA Label Image

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 08)

FDA Label Image

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 09)

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 09)
This is a description for a medication containing sacubitril and valsartan. Each film-coated tablet contains 24 mg of sacubitril and 26 mg of valsartan. The usual dosage information should be obtained from the prescribing information. The tablets should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F). The medication should be protected from moisture. It is important to keep this and all drugs out of the reach of children. The tablets are manufactured for Somerset Therapeutics, LLC in Somerset, NJ 08873. The product is made in Chile.*
FDA Label Image

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 10)

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 10)
Each film-coated tablet contains 24 mg of sacubitril and 26 mg of valsartan. The usual dosage information can be found in the prescribing information. Store these tablets at 20°C to 25°C, with excursions allowed between 15°C and 30°C. Protect from moisture and keep out of reach of children. Manufactured for Somerset Therapeutics, LLC.*
FDA Label Image

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 11)

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 11)
This is a description of a prescription medication with the NDC number 70069-854-60. The medication is a film-coated tablet that contains 49 mg of sacubitril and 51 mg of valsartan. The usual dosage information can be found in the prescribing information. It is advised to store the tablets between 20°C to 25°C (68°F to 77°F) and excursions between 15°C and 30°C (59°F and 86°F) are permitted. The tablets should be protected from moisture. The medication is manufactured for Somerset Therapeutics, LLC in Somerset, NJ.*
FDA Label Image

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 12)

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 12)
This is a prescription medication containing 49 mg of sacubitril and 51 mg of valsartan per film-coated tablet. It is important to follow the usual dosage as per the prescribing information. The tablets should be stored at temperatures between 20°C to 25°C (68°F to 77°F), with excursions allowed between 15°C and 30°C (59°F and 86°F). Ensure the medication is protected from moisture and kept out of reach of children. Manufactured for Somerset Therapeutics, LLC in Chile, this product comes in a container with 180 tablets.*
FDA Label Image

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 13)

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 13)
This is a medication containing sacubitril and valsartan, with each film-coated tablet containing 97 mg of sacubitril and 103 mg of valsartan. The usual dosage should be followed as per prescribing information. Store the tablets at a temperature between 20°C to 25°C (68°F to 77°F) and excursions are permitted between 15°C and 30°C (59°F and 86°F). Protect the tablets from moisture and store them away from children. The tablets are manufactured for Somerset Therapeutics, LLC in Somerset, NJ.*
FDA Label Image

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 14)

Image (0e853a5e 9eab 4bb6 803d Fd9b97e8b550 14)
This is a prescription medication with the NDC number 70069-855-80. It is sacubitril and Valsartan tablets. Each film-coated tablet contains 97 mg of sacubitril and 103 mg of valsartan. The usual dosage should be followed as per the prescribing information. It is advised to store the tablets between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F) as per USP Controlled Room Temperature guidelines. The medication should be protected from moisture and kept out of reach of children. This product is manufactured for Somerset Therapeutics, LLC in Somerset, NJ and is made in Chile.*
FDA Label Image

Image (70f2f2a9 Cfc1 422d B7d1 8666f0d4e02d 113 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.